COVID-19

Views & Analysis

COVID-19 and the digital pharma marketing revolution

The global pandemic has caused pharma companies to invest in digital marketing, as healthcare systems across the world adapt to strict lockdown rules.

News

Pfizer/BioNTech shot may beat new virus mutation, study find...

The Pfizer/BioNTech vaccine appears to work against an important mutation in the new coronavirus variants causing havoc in the UK and South Africa, according to research from the drugs gian

News

Moderna’s COVID-19 vaccine is third approved in UK

The UK has approved the Moderna coronavirus vaccine, hard on the heels of its go-ahead in Europe, although supplies are not expected to arrive for several weeks.

News

Blurred figures of people with medical uniforms in hospital corridor

IL-6 drugs do work in COVID-19, says UK, as it plans NHS use

New data means that IL-6 drugs from Roche and Sanofi that had been all-but written off as coronavirus therapies will now be offered routinely to COVID-19 patients in intensive care in the

Views & Analysis

True patient-focused research through decentralised and hybr...

How can pharma improve the patient-centricity of its trials during COVID-19 and beyond?

Views & Analysis

Resourceful or risky? The UK’s controversial COVID-19 vaccin...

As COVID-19 vaccines are hastily deployed in the UK for priority groups, a debate rages over the government’s controversial strategy to delay time between vaccine doses.

COVID-19 and the digital pharma marketing revolution

Pfizer/BioNTech shot may beat new virus mutation, study find...

Moderna’s COVID-19 vaccine is third approved in UK

IL-6 drugs do work in COVID-19, says UK, as it plans NHS use

True patient-focused research through decentralised and hybr...

Resourceful or risky? The UK’s controversial COVID-19 vaccin...

BioNTech sticks with cancer vaccine despite trial miss

Discover a new era of healthcare panel engagement: Grounded ...

COVID-19

Editor's Picks